Cardio Diagnostics Holdings (CDIO) Shares Outstanding (Weighted Average) (2021 - 2025)
Cardio Diagnostics Holdings' Shares Outstanding (Weighted Average) history spans 5 years, with the latest figure at $1.8 million for Q3 2025.
- For Q3 2025, Shares Outstanding (Weighted Average) rose 132.16% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $1.8 million, up 132.16%, while the annual FY2024 figure was $26.9 million, 112.0% up from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 was $1.8 million at Cardio Diagnostics Holdings, up from $1.7 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $26.9 million in Q4 2024 and bottomed at $702574.0 in Q1 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $3.7 million (2022), against an average of $6.1 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) surged 310.83% in 2023 before it tumbled 93.64% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.2 million in 2021, then skyrocketed by 165.44% to $3.1 million in 2022, then soared by 310.83% to $12.7 million in 2023, then soared by 112.0% to $26.9 million in 2024, then crashed by 93.46% to $1.8 million in 2025.
- Per Business Quant, the three most recent readings for CDIO's Shares Outstanding (Weighted Average) are $1.8 million (Q3 2025), $1.7 million (Q2 2025), and $1.7 million (Q1 2025).